Get started

Weedstocks

GrowGeneration | GRWG | Long at $1.90GrowGeneration NASDAQ:GRWG is approaching one of my favorite technical analysis setups as it gets closer to my selected historical simple moving average (SMA: the white and teal lines). Often, but not always (i.e. public offering news...), the price will jump to the selected historical SMA after a long period of consolidation - which has been occurring for some time. Additionally, the President, CEO, and Director of NASDAQ:GRWG have been buying shares recently near $2 which is a bullish indicator. There are currently only 54.8 million floating shares and an 8%+ short interest, so this could get interesting if the election cycle whips up new interest/chatter about national decriminalization of marijuana. As a result, GrowGeneration is in a personal buy zone at $1.90. Target #1 = $2.20 Target #2 = $2.50 Target #3 = $3.00 Target #4 = $3.50
NASDAQ:GRWGLong
by NicksAnalysis
WM Technology | MAPS | Long at $1.00WM Technology NASDAQ:MAPS provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. After it's de-SPAC in 2020, it soared to $29.50 and now can be found for around $1.00. It's been consolidating at these lows for almost two years, and it may be gaining algorithmic traction for a move soon based on my selected simple moving average (SMA). Often (but not always), when this SMA gets close to the price, there is a pop to the historical SMA. Currently, it is in a personal buy zone at $1.00. Target #1 = $1.50 Target #2 = $2.00
NASDAQ:MAPSLong
by NicksAnalysis
send $acb back to $1002024 has been very busy for NASDAQ:ACB - Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia - Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free - Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis - Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation when looking at the chart we can see obvious price discovery to the downside, and the last year of lows have come with heavy market selling. however on the plus side the buy pressure has been positive in the background suggesting someone is happy to scoop up the stock down here. its only a matter of time before NASDAQ:ACB picks up again given the company are now debt free :-)
NASDAQ:ACBLong
by TBTS
3
"Canopy Growth Corporation Faces Critical Support Test"Canopy Growth Corporation: Navigating Market Challenges and Strategic Goals Canopy Growth Corporation, a prominent player in the cannabis industry, has been a focal point for investors seeking exposure to the rapidly expanding market for legal marijuana products. As one of the largest cannabis producers globally, Canopy Growth has garnered attention for its ambitious goals and strategic initiatives aimed at capitalizing on the burgeoning demand for cannabis-related products. Founded in 2013, Canopy Growth has quickly risen to prominence, establishing itself as a leader in the cannabis industry through a combination of strategic acquisitions, innovative product development, and global expansion efforts. The company's primary focus is on cultivating, producing, and distributing a diverse range of cannabis products, including dried flower, oils, edibles, and beverages. In recent years, Canopy Growth has achieved several notable milestones, reflecting its commitment to growth and innovation. These achievements include expanding its production capacity, securing distribution agreements with leading retailers, and launching new product lines to meet evolving consumer preferences. However, despite its successes, Canopy Growth has faced challenges in navigating the volatile cannabis market, particularly in the wake of a prolonged distribution bear market that has persisted for the past five years. The company's stock price has experienced significant fluctuations, reflecting the uncertainty surrounding regulatory environments, shifting consumer trends, and competitive pressures within the industry. Recently, Canopy Growth's stock price experienced a sharp retracement, testing critical support levels around $18 per share. With the stock now poised to retest its previous lows at $4 per share, investors are closely monitoring the situation for signs of a potential breakout or breakdown. The recent spike in volume accompanying the bounce from support suggests heightened volatility and the potential for significant price movements in the near term. Bears may attempt to crack support levels, with the possibility of a further downward spiral if volume flows through aggressively enough. In such a scenario, the stock could potentially retest long-term downward support levels around $2 per share. On the other hand, if Canopy Growth manages to break out of its current pennant pattern, investors may view this as an opportunity to enter a position targeting the top of long-term resistance levels. A successful breakout could pave the way for renewed upward momentum, offering potential upside for savvy traders. In conclusion, Canopy Growth Corporation continues to navigate challenges in the cannabis market while pursuing strategic goals aimed at driving long-term growth and profitability. As the company grapples with support levels and potential breakout opportunities, investors should remain vigilant and adaptable, prepared to capitalize on emerging trends and developments in this dynamic industry.
NASDAQ:CGC
by UnknownUnicorn2319099
3
TLRY's Green Revolution Cannabis Stocks on the NYSEAs of the most recent data, the S&P 500, which represents the performance of 500 of the largest companies listed on stock exchanges in the United States, is trading at an impressive level. The index has been on a bullish trend, consistently reaching new all-time highs in recent months. This upward trajectory can be attributed to a combination of factors, including strong corporate earnings, optimism surrounding economic recovery, and accommodative monetary policies from central banks. Investors' appetite for risk remains robust, and as long as these favorable conditions persist, the S&P 500's bullish trend is likely to continue, attracting both institutional and retail investors.
NASDAQ:TLRYLong
by DEXWireNews
2
GRWG buy the dip!First off for summary: Grow Generation is a leading retailer of hydroponic and organic gardening products in the United States. The company was founded in 2014 and is headquartered in Denver, Colorado. Grow Generation provides a wide range of products and services for indoor and outdoor gardening, including hydroponic and organic growing equipment, nutrients, and supplies. The company operates more than 30 retail locations in 13 states and is committed to providing high-quality products, expert advice, and excellent customer service to its customers. With a growing customer base of professional cultivators and home gardeners, Grow Generation is well positioned for continued growth in the hydroponic and organic gardening industries. TA: It is very clear we are under the 5year trend line. In 2018/2019 when GRWG was at these prices the revenue was a 4th of what it is now so even with the marco economic outlook uncertain, I think this is a great buying opportunity. These guys are growing at a healthy rate and there is still a large untapped market in the midwest that they are positioned well to capture. I've been watching more and more folks convert from alcohol to delta 8 products and it's only a matter of time before the feds decriminalize delta 9 sales. I think we will break above $10 by summer. If we test new lows I'd reconsider.
NASDAQ:GRWGLong
by lillybear
1
Aurora: Sleeping Beauty 👸It's time to activate our wake-up call to get Aurora back into motion, since we expect the course to rise up North, even though it is still creeping sideways momentarily. In our alternative scenario, there is a slight probability of 33% that the course could drop below the $1.14 support line instead. In this case, it would continue to move South until it reaches the low of the grey wave alt. II. Primarily, the stock should make the climb and fulfill the blue wave (iii) before dropping into a correction of the blue wave (iv). Once completed, the course should have gained momentum to be able to exceed the resistance line at $2.49 and wander further North in order to complete the pink wave .
TSX:ACB
by MarketIntel
Canopy Growth: Ball Drop 🪩Just like the Ball in Times Square every New Year's Eve, the Canopy Growth stock is currently dropping it low. We expect the course to dig deeper into the blue trading area between C$3.49 and C$0.70 until it finishes the grey wave II. After completion, we're expecting the course to rise further North in the longterm. In our alternative scenario, the Canopy Growth stock course might exceed the C$5.55-mark already now, without pushing for further lows below the support line.
TSX:WEED
by MarketIntel
1
$PSIL Bombed out #Weed #ETF $MSOS attacking resistance lines...Will it pull up the AdvisorShares Psychedelics ETF? Strength in the #Biotech sector would also be a friendly situation. here are the top holdings: CMPS COMPASS PATHWAYS PLC 13.12% ATAI ATAI LIFE SCIENCES NV 9.73% CYBN CYBIN INC 7.97% SEEL SEELOS THERAPEUTICS INC 6.90% ITCI INTRA-CELLULAR THERAPIES INC 6.44% HUGE FSD PHARMA INC-CLASS B 5.82% SAGE SAGE THERAPEUTICS INC 5.23% ALKS ALKERMES PLC 4.84% DRUG BRIGHT MINDS BIOSCIENCES INC 4.70% I can see this ETF targeting $3.2 as its first port of call.
AMEX:MSOSLong
by BallaJi
Bargain Hunting - OBV Divergence?This is just a thought here - although this appears to be a never-ending downtrend, I wonder if this on-balance volume divergence signals something. This shows that buyers are willing to step in here a bit more aggressively than the previous "bottom," as shown by higher OBV despite lower prices - even though OBV has declined overall since its peak. We're also seeing higher OBV in general since 2021, which could signify aggressive accumulation despite continued decline in value. This sort of behavior can be seen throughout the cannabis industry. ACB is roughly 98-99% down from its all-time high. Not that it could ever get back up there, but I think at least a return to the $6-7 range is possible over the coming months. However, since the downtrend has technically not ended, there is still significant risk of continuation to the downside. Seems worth a speculative gamble though, as per my last stock analysis and being "strategic." Overall, I'm only down 12% on stocks since I started investing slowly since last year. Not too bad, considering how far down big tech has tumbled. That's probably because I've stayed away from big tech, and been pretty careful about investing too much in weed stocks, at least until prices started to get obscenely low. I also managed to stabilize my portfolio by investing in Uranium ETF's, which helped a bit. -Victor Cobra
NASDAQ:ACBLong
by VictorCobra
Weed Stocks Bottom We are not out of the weeds yet. Get it? stupid dad Joke We are back down to buying prices and with inflation/fed rates priced in we've had a good month. If we can break and hold above the downtrend line we could see a little rally to $6-$8 range. I don't think it will last long though and we will more likely have a double bottom. Seems like federal legalization is still a ways off, and marijuana market growth is slowing. Just charting and sharing thoughts. Happy to hear feedback.
NASDAQ:TLRY
by lillybear
5
Up In Smoke - MJ burning downA great 2x inverse ETN for this recession is MJIN, which is opposite of MJXL. By early morning of June 8, SMG reported less expected FY22 earnings, sales & profits. This largely affects weed ETFs due to heavy use of their products for growing, as we can see the spike here shortly after the news broke. In this case, due to rising inflation across the economy, most cannabis users will likely go underground to unregulated markets to find somewhat cheaper MJ. So take this ETN & get high.
MLong
by roelds